Last Updated: June 22, 2026

FLUOCINOLONE Drug Patent Profile

Name: FLUOCINOLONE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Fluocinolone patents expire, and when can generic versions of Fluocinolone launch?

Fluocinolone is a drug marketed by Allied, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Invatech, Perrigo New York, Pharmafair, Sun Pharma Canada, Usl Pharma, Amneal, Padagis Israel, Quagen, Rising, Sciegen Pharms, Tp Anda Holdings, Glenmark Pharms Ltd, Novel Labs Inc, Pharmaderm, Actavis Labs Ut Inc, Bausch And Lomb, Chartwell Rx, Encube Ethicals, Lupin, and Pai Holdings Pharm. and is included in fifty-six NDAs.

The generic ingredient in FLUOCINOLONE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Fluocinolone

A generic version of FLUOCINOLONE was approved as fluocinolone acetonide by FOUGERA PHARMS INC on December 16^th, 1982.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FLUOCINOLONE?
What are the global sales for FLUOCINOLONE?
What is Average Wholesale Price for FLUOCINOLONE?

Summary for FLUOCINOLONE

US Patents:	0
Applicants:	24
NDAs:	56
Drug Prices:	Drug price information for FLUOCINOLONE
DailyMed Link:	FLUOCINOLONE at DailyMed

Drug patent expirations by year for FLUOCINOLONE

US Patents and Regulatory Information for FLUOCINOLONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmaderm	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OINTMENT;TOPICAL	088046-001	Dec 16, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Quagen	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OIL;TOPICAL	212760-001	Apr 2, 2021	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Chartwell Rx	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	SOLUTION;TOPICAL	209596-001	Dec 26, 2017	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Actavis Labs Ut Inc	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	SOLUTION;TOPICAL	208386-001	Oct 21, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for FLUOCINOLONE

Fluocinolone topical coupon?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.